GW Pharmaceuticals Plc
(NASDAQ : GWPH)

( )
GWPH PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
MDCOMedicines Company
-2.46%47.5020.3%$144.62m
VRXValeant Pharmaceuticals International, Inc.
0.09%23.3714.1%$137.51m
AMRNAmarin Corporation Plc Sponsored ADR
0.46%17.331.8%$107.00m
PRGOPerrigo Co. Plc
0.04%56.706.8%$63.96m
JAZZJazz Pharmaceuticals Plc
0.00%134.012.3%$63.68m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-2.82%137.036.2%$59.04m
SAGESAGE Therapeutics, Inc.
0.00%165.358.6%$58.81m
ENDPEndo International Plc
2.14%4.298.8%$45.48m
CTLTCatalent Inc
-1.46%50.602.4%$43.11m
MNKMallinckrodt Plc
1.33%3.0520.9%$42.09m
ICPTIntercept Pharmaceuticals, Inc.
4.86%72.2516.9%$32.57m
UTHRUnited Therapeutics Corporation
0.00%83.5314.3%$32.45m
AERIAerie Pharmaceuticals, Inc.
7.92%23.846.8%$29.31m
ICLRICON Plc
0.35%150.444.1%$28.60m
PTLAPortola Pharmaceuticals, Inc.
1.53%31.156.7%$28.57m

Company Profile

GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its lead cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.